Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and CTNNB1 Translocation

被引:2
|
作者
Boyraz, Baris [1 ,5 ]
Paula, Arnaud da Cruz [2 ]
Deveraux, Kelly A. [4 ]
Tran, Ivy [4 ]
da Silva, Edaise M. [3 ]
Young, Robert H. [1 ]
Snuderl, Matija [4 ]
Weigelt, Britta [3 ]
Oliva, Esther [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, James Homer Wright Pathol Labs, Boston, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA
[4] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA
[5] Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren Bldg, Boston, MA 02114 USA
关键词
endometrial stromal tumor; CTNNB1; beta-catenin; MENINGOTHELIAL-LIKE WHORLS; NUCLEAR BETA-CATENIN; ENDOMETRIAL; SARCOMAS; FEATURES; DIFFERENTIATION; LIPOSARCOMA; EXPRESSION; NEOPLASMS; UTERUS;
D O I
10.1097/PAS.0000000000002094
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Endometrial/endometrioid stromal tumors are rare and morphologically heterogenous, and their diagnosis may be challenging. We identified 3 endometrial/endometrioid stromal tumors with identical and previously undescribed histologic features and herein report their morphologic, immunohistochemical, and molecular profiles. Patients were 53, 62, and 79 years. Tumors were well-circumscribed, tan-yellow solid masses measuring 10.0, 11.0, and 18.7 cm, and were intramyometrial (n=2) or in the broad ligament (n=1). All showed small, tight whorls of epithelioid to slightly spindled tumor cells with minimal cytoplasm and negligible mitoses, multifocally associated with hyalinization and myxoid change set in a loose fibroblastic background with small, delicate vessels. This morphology was seen throughout in 1 tumor and in similar to 20% and 70% of the 2 others with the remaining areas showing sex cord-like differentiation. Tumor cells expressed CD10 (3/3, 1 focal), calretinin (3/3 diffuse), WT1 (3/3 diffuse), estrogen receptor (1/1, diffuse). RNA-sequencing was successful in 1 tumor and revealed a GREB1-CTNNB1 in-frame fusion. All 3 tumors harbored a CTNNB1 translocation by fluorescence in situ hybridization correlating with nuclear beta-catenin expression. Whole-genome DNA methylation analysis classified all 3 tumors within the low-grade endometrial stromal sarcoma reference class with flat copy number profiles. One patient (79-y-old) died of unrelated causes 2 months after surgery and the other 2 were alive without disease after 13 and 75 months. We have described a rare subset of endometrial/endometrioid stromal tumors with extensive whorling and a CTNNB1 translocation, expanding the morphologic and molecular spectrum of these neoplasms.
引用
收藏
页码:1285 / 1290
页数:6
相关论文
共 50 条
  • [32] Prognostic significance of CTNNB1 mutation in recurrence of sporadic desmoid tumors
    Guo, Lifang
    Wang, Xin
    Xu, Benshan
    Lang, Ren
    Hu, Bin
    FUTURE ONCOLOGY, 2020, 17 (04) : 435 - 442
  • [33] CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation with Patient Outcome
    Zyla, Roman
    Amemiya, Yutaka
    Olkhov-Mitsel, Ekaterina
    Bassiouny, Dina
    Seth, Arun
    Djordjevic, Bojana
    Nofech-Mozes, Sharon
    Parra-Herran, Carlos
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1171 - 1171
  • [34] CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component
    Roukain, Abdallah
    Sykiotis, Gerasimos P.
    MODERN PATHOLOGY, 2021, 34 (11) : 2087 - 2088
  • [35] CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation with Patient Outcome
    Zyla, Roman
    Amemiya, Yutaka
    Olkhov-Mitsel, Ekaterina
    Bassiouny, Dina
    Seth, Arun
    Djordjevic, Bojana
    Nofech-Mozes, Sharon
    Parra-Herran, Carlos
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1171 - 1171
  • [36] CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma Correlation With Patient Outcome
    Zyla, Roman E.
    Olkhov-Mitsel, Ekaterina
    Amemiya, Yutaka
    Bassiouny, Dina
    Seth, Arun
    Djordjevic, Bojana
    Nofech-Mozes, Sharon
    Parra-Herran, Carlos
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (01) : 68 - 76
  • [37] Synchronous endometrioid carcinomas of the uterine corpus and ovary:: alterations in the β-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis
    Irving, JA
    Catasús, L
    Gallardo, A
    Bussaglia, E
    Romero, M
    Matias-Guiu, X
    Prat, J
    HUMAN PATHOLOGY, 2005, 36 (06) : 605 - 619
  • [38] Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma
    Chibbar, Rajni
    Foerstner, Sabrina
    Suresh, Janarathnee
    Chibbar, Richa
    Piche, Alexandre
    Kundapur, Deeksha
    Kanthan, Rani
    Kundapur, Vijayanand
    Lee, Cheng Han
    Agrawal, Anita
    Lai, Raymond
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2023, 31 (03) : 181 - 188
  • [39] Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation
    Naoki Kojima
    Hiroshi Yoshida
    Masaya Uno
    Kengo Hiranuma
    Tomoaki Naka
    Kouya Shiraishi
    Tomoyasu Kato
    Virchows Archiv, 2022, 481 : 799 - 804
  • [40] Identification of Large Deletions Affecting CTNNB1 Exon 3 in Solid Tumors
    Zhang, Z.
    Wei, C.
    Li, B.
    Liu, C.
    Bi, T.
    Guo, P.
    Qiu, F.
    Wang, H.
    Ye, J.
    Lin, J.
    Zhang, Q.
    Zhang, G.
    Kuang, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S50 - S51